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Abstract: This study advances current knowledge on building a brand strategy that includes corporate reputation. It employs three theories – value creation, 
strategic resources and corporate communication – to study the uses of corporate reputation and its effect on brand segmentation, brand differentiation and 
brand positioning. In the context of the Taiwanese pharmaceutical industry, a sequential mixed method approach is applied and data are analyzed using PLS 
SEM. Findings demonstrate the relative impacts of three uses of corporate reputation (value creation, strategic resources and corporate communication) on 
brand image strategy (brand segmentation, brand differentiation and brand positioning) and the implications are evaluated. This study discovers that the 
inclusion of medicine prices is necessary and that it negatively moderates the impact of the overall uses of corporate reputation on overall brand image 
strategy. This research contributes empirically as one of the few that tests reputation-and-branding-building models outside the USA and Europe. 
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A firm’s reputation not only enhances the value of corporate image (Fombrun 1996), but it also has an effect on other organizational functions, such as brand 
advertising (Gianfranco and Beatty 2007; Gotsi and Wilson 2001). Yet, despite its importance, researchers argue that the issue of brand reputation in 
industrial markets has received little attention relative to that accorded to it in consumer markets (Han et al. 2015; Mukherjee and Balmer 2007; Simoes et al. 
2005). Given the importance of a firm’s reputation, it is worthwhile to investigate the concept further in order to harmonize with existing research (e.g., Low 
and Blois 2002; Varadarajan et al. 2006). The present study explores the uses of corporate reputation and its relationship with brand image, brand 
segmentation, brand differentiation, and brand positioning.  
To date, few studies have theoretically investigated how firms use their corporate reputation to enhance their brand image strategy in terms of brand 
segmentation, differentiation and positioning in a single, comprehensive study. Based on this assertion and focusing on the Taiwanese pharmaceutical 
industry, the question that will be addressed throughout this research shall be: How do Taiwanese pharmaceutical companies use their corporate reputations 
to develop their brand segmentation, differentiation and positioning strategy? The research explores how firms can use their corporate reputation to enhance 
their overall brand strategy and it has two main research objectives:  (1) To develop a model that explains the effects of the uses of corporate reputation in 
pharmaceuticals on the brand image strategy (segmentation, differentiation and positioning) of brand managers; and  (2) To empirically test the model in a 
  
non-Western setting in order to examine the external validity (i.e. the applicability of these theories in other contexts) of Western-developed theories. This 
includes the assessment of the dimensionality and operationalization of key constructs.  
The purpose of using the pharmaceutical research context stems from the observation that pharmaceutical companies require a good reputation to 
survive. Pharmaceuticals are encouraged to develop a good reputation for their quality of product and services, innovativeness, honest communication and 
environmental responsibilities (Achilladelis and Antonakis 2001; Fombrun and Shanley 1990). In turn, these factors can also be converted subconsciously 
into the brand image of the products that belong to a company (Panigyrakis and Veloutsou 1999). Because a firm’s corporate reputation tends to highly 
influence the initiation of brand strategy decisions and brand scene-setting in pharmaceutical companies (Nakra 2000), this context provides an excellent 
context for the present study.  
In addition, existing literature shows that the majority of previous studies about the uses of corporate reputation have been completed in Western 
countries (the USA, the UK, Germany, Australia, Japan, Germany and the Netherlands, etc.) and focus less on investigating the topic in other regions (e.g. 
Asia, Africa, or South America), which have therefore limited any generalisability of theory (Boyacigiller and Adler 1991; Trompenaars and Hampden-
Turner 1998). The present study aims to test these theories in the Taiwanese context to advance current knowledge on building a brand strategy for firms. 
Using their corporate reputation to create or align with their brand image strategy thus offers practical insights to managers and academics alike. 
 
Hypotheses development 
The main construct of this study, that is the uses of corporate reputation, consists of three dimensions, namely, value creation, strategic resources and 
corporate communication (Chen et al. 2015). First, the uses of corporate reputation as a value-creation tool include promising good quality products and 
services to customers, reducing transaction costs and sending signals to its customers. Second, the uses of a firm’s corporate reputation as a strategic resource 
include use as a competitive advantage, as a strategic value or resource, and development of good financial performance. Third, the uses of corporate 
reputation as a communication tool include shaping the perception of shareholders and stakeholders, influencing consumer choices and building a relationship 
between the firm and its customers. This framework has been developed by summarizing and synthesizing the works of a number of scholars (e.g., Fombrun 
and Shanley 1990; Sabate and Puente 2003) who have previously studied the uses of corporate reputation.   
< Insert Figure 1 About Here > 
 
Value creation and brand image strategy  
The value provided by a firm to a customer is judged during the customer purchasing process. Therefore, the value creation ability of a firm is deeply related 
to the relationship with its customers and influences the perception of its customers. In essence, the resource-based theory (Grant 1991; Peteraf 1993) 
provides a general approach for a firm to find its core value. The resource-based theory suggests that a firm can achieve superior returns by exploiting internal 
resources and capabilities. Corporate reputation is commonly used by a firm as a strategic resource (Roberts and Dowling 2002) or as a tool for the 
development of organizational value (Smith 1994). Since corporate reputation cannot be bought and is not easy to imitate or substitute, it is therefore regarded 
as an asset for a firm (Barney 1986; Bromley 2002).  
  
The value-based theory underlines the following hypotheses. Theory aims to better understand the intentions and mind-interaction in consumers when 
they try to evaluate the benefits that can be derived from a brand or a product. Incorporating the customer value-based theory of the firm makes it easier to 
understand a firm’s management strategy (Slater 1997). Such a focus is understandable for an effective management strategy nowadays because market forces 
predominantly drive strategic decision-making (Cravens 1998). Specifically, Schwartz and Bilsky (1987) claim that values are cognitive representations of 
universal human requirements: biological needs, social interactional requirements and social institutional demands on the individual. Subsequently, some 
scholars – Parasuraman (1997) and Woodruff (1997) – proposed that a thorough understanding is needed to clarify the complexities of customer value 
perceptions, the processes for customer value monitoring and the processes for leveraging the firm knowledge. These help to validate the strategy the 
managers follow by creating, developing, and delivering value to the customers (Flint 2004). 
Human values have been increasingly used as a basis for market segmentation (Kamakura and Novak 1992). Flint (2004) argues that customer 
valued-based strategy resides in segmentation, branding, positioning, integrated marketing communication, professional selling, advertising, pricing, product 
development and distribution/logistics strategies. It is further noted from the arguments above that the value system has been used by marketers to explain 
phenomena such as consumer behavior (Henry 1976), as well as strategic management (Flint 2004). Specifically, creating a value-based strategy relating to 
customers’ gains enhances the reputation for a firm. It can thus be hypothesized that a firm with good corporate reputation as an intangible asset can benefit a 
firm by reducing transaction costs, indirectly creating value. Given this study’ focus on the relationship between value creation and branding strategy, it is 
therefore proposed that: 
H1:  Value creation as a dimension of the uses of corporate reputation has a positive impact on a firm’s brand segmentation strategy. 
H2:  Value creation as a dimension of the uses of corporate reputation has a positive impact on a firm’s brand differentiation strategy. 
H3:  Value creation as a dimension of the uses of corporate reputation has a positive impact on a firm’s brand positioning strategy. 
 
Strategic resource and brand image strategy: influencing a competitor’s actions/strategies  
The inclusion of the resource-based view (RBV) of a firm may explain well our propositions presented below. The RBV has been extensively summarized in 
contemporary strategy literature (Mahoney 1995; Wernerfelt 1995). Barney (1991) defined resources as a bundle of assets, capabilities, organizational 
processes, firm attributes, information and knowledge. These resources can be broadly categorized as tangible and intangible and consist of financial, 
physical, legal, human, organizational, relational, technological and informational assets, skills and competencies. Resource-based scholars suggest that 
certain assets (tangible or intangible) with certain characteristics will lead to sustainable competitive advantage (Hooley et al. 1998).  Resource-based 
theorists suggest that for a strategy to be sustainable it needs to be embedded in the firm’s resources and capabilities. For example, Grant (2010) argues that 
rates of change in the external environment increase firms’ abilities to base their long-term strategies on internal resources and capabilities rather than focus 
on external market forces. It is also proposed by Varadarajan and Jayachandran (1999) that organizational issues (e.g. corporate reputation) are relevant to 
management strategies such as branding, competitive behavior, positioning, and segmentation, and have an impact on quality management, marketing and 
business strategy (e.g. market orientation), and outcomes of a market strategy (e.g. market share, customer satisfaction).  
Therefore, based on the resource-based theory (and market orientation), corporate reputation has been regarded by many researchers as a strategic 
resource of a firm (Wernerfelt 1995), which explains the rent-earning capability of resources (see Amit and Schoemaker 1993). This dynamic capability 
  
approach examines how resources and capabilities are developed in a firm context (Mahoney 1995) and will also be developed into a competitive positioning 
strategy (Hooley et al. 1998). Hooley et al. (1998) reconcile the market orientation and resource-based view by developing a positioning strategy concept. 
While several main approaches to resources have been developed, previous researchers have predominantly investigated the strength of corporate reputation 
as a strategic resource of a firm. In this research, we follow this assertion to view corporate reputation as one of the firm’s intangible assets. Given that the 
focus of the study is on the relationship between the strategic resource role of corporate reputation for the brand image strategy, it is thus proposed that: 
H4:  Strategic resource as a dimension of the uses of corporate reputation has a positive impact on a firm’s brand segmentation strategy. 
H5:  Strategic resource as a dimension of the uses of corporate reputation has a positive impact on a firm’s brand differentiation strategy. 
H6:  Strategic resource as a dimension of the uses of corporate reputation has a positive impact on a firm’s brand positioning strategy. 
 
Corporate communication: developing the relationship with its stakeholders and brand image strategy 
Corporate communication directly influences consumer perception and creates competitive advantage for a company (Gray and Balmer 1998). Corporate 
reputation is used to communicate a firm’s social responsibility activities to stakeholders within the business environment. For instance, although a medicine 
brand may have excellent medical performance, the manufacturer may use other forms of its firm’s reputation to transmit a different image to their brands. 
Hence, it may select a representation of an experience with this pharmaceutical corporation as being ‘safe’ or trustable (e.g. “It was very reliable and can be 
trusted when I prescribed the medicine to my patient).” 
Corporate reputation can be positioned to a specific target group that enhances the generation of better feedback from stakeholders within the business 
environment. According to an parallel school of thought (Fombrun and Shanley 1990), corporate reputation is developed on the basis of consumer perception. 
Therefore, managers portray corporate reputation as a benefit for the customers, because when they feel more secure about a firm’s ability they will buy more. 
Moreover, a firm’s reputation can influence customer choice. Studies observe that a corporate reputation helps customers to select the best choice among 
many alternatives in the market. Landon and Smith (1997) and Sabate and Puente (2003) also confirmed that corporate reputation is used by customers to 
make purchasing decisions. Corroborating this point of view, it is suggested that a good corporate reputation enables the generation of increased customer 
loyalty. 
Several researchers have suggested that a firm’s communications have a direct impact on setting the scene for segmenting and positioning a firm’s 
product, either in direct marketing or in other service sectors. To be more specific, a firm’s use of communication in any form (e.g. package design, logo 
design, distribution channel and salesperson) creates a platform to make their customers understand more about themselves and their products (or services), 
making it easier for brand managers to target their branding strategy to a clearly defined or segmented market group. Given that the focus of the study is on 
the uses of corporate reputation - and that shaping the perception of shareholders and stakeholders plays a role of communication in a company’s branding 
strategy - it is proposed that: 
H7:  Corporate communication as a dimension of the uses of corporate reputation has a positive impact on a firm’s brand segmentation strategy. 
H8:  Corporate communication as a dimension of the uses of corporate reputation has a positive impact on a firm’s brand differentiation strategy. 
H9:  Corporate communication as a dimension of the uses of corporate reputation has a positive impact on a firm’s brand positioning strategy. 
 
  
Methodology 
Research setting 
Companies in a single industry were chosen as the setting for this research. Certain considerations led to this choice. First, the single-industry design provided 
the researchers with better control over market and environmental anomalies and industry effects. That is, a single industry is more focused on a particular 
manufacturing procedure, ways of marketing goods and maintaining customer relationships. Second, it was desirable to study a setting in which: (1) the three 
dimensions of the uses of corporate reputation could be explained and clearly measured; (2) corporate reputation plays an important role in the general 
operations and the survival of businesses; (3) previous research has identified the presence of various types of strategic use of a firm’s intangible assets, 
communication and value creation activities, and (4) reliable and adequate data are available for the purification of measurement scales and hypothesis 
testing. 
Given the factors described above, the pharmaceutical industry was chosen because reputation building is particularly important for it: medicines are 
considered vital for human life and thus corporate reputation plays an important role in the general operations and the survival of business. Furthermore, a 
pharmaceutical firm can use its reputation to signal its customers about its new technology, the standards they require or just to build trust with its customers. 
As a result they might get a higher price for their products. The managers in this industry make mainly strategic decisions on the use of a firm’s intangible 
assets, its corporate communication and value-creation activities.  
Furthermore, in order to test the validity of Western-developed theories, several researchers (e.g. Boyacigiller and Adler 1991; Peng and Shyi 1991) 
recommend collecting data in a non-Western country. Taiwan, one of the most dynamic business environments in Asia, was selected as the setting of this 
study for several reasons. First, Taiwan is culturally similar to its Asian neighbors (e.g. China) and clearly different from Western countries (Hofstede 1980), 
where most of the corporate reputation studies have been carried out. Second, Taiwan is one of the fastest-growing economies of the newly industrialized 
countries. Much of its growth has come from multinational companies and is also the home to the regional headquarters of many multinational companies in 
Asia. Third, Taiwan has a high credit rating internationally due to its stable and dynamic business environment (Economist Information Unit; EIU 2012). 
Finally, the values and norms of Taiwanese consumers have strong roots in Chinese folk religion, making Taiwan very different from the USA, UK, and other 
developed countries.  
 
Qualitative data collection 
Fourteen brand managers from pharmaceutical companies in Taiwan were used as respondents. The majority of the companies (81.25 per cent) and their 
respondents had a 31- to 50-year corporate history. The majority of the companies (75 per cent) had fewer than 100 employees. More than half (56.25 per 
cent) were original companies or dealers of European or American pharmaceuticals, and more than half (56.25 per cent) of the companies had less than 150 
million TW dollars turnover. The interviewees answered the semi-structured interview questionnaire to gain a better perspective on the relationship between 
the hypotheses and related issues. They were able to provide information about how their firms’ current situation affect their corporate strategy. In conducting 
the interviews, questions based on the measurement items of each construct were asked. For example, for the uses of corporate reputation construct, questions 
such as: “What do you think are the uses of corporate reputation dimensions?” and “Why?” were employed. Furthermore, content and face validity were also 
  
examined in this step (Netemeyer et al. 2003). Specifically, respondents were asked to indicate their opinion on the clarity and comprehensibility of 
questionnaire items. 
Following Miles and Huberman (1994), the researcher extracted items from interview data by using the data reduction and display functions in Nvivo 
7 software. A coding scheme was designed based on literature and transcripts. Data were grouped according to relevant codes. Items were subsequently drawn 
from each group and compared with those obtained from the relevant literature. The information from the interviews was integrated with the items 
regenerated from the literature. The questionnaire statements for these items were then constructed by the researchers and a pilot test was conducted to test the 
research instrument. 
 
The main study 
Data collection method 
The researchers started their investigation by contacting a relevant professional association to ask for its support and for more information about the 
Taiwanese pharmaceutical companies. The Taiwanese BNHI (Bureau of National Health Insurance) provided a list of contacts of its association members. 
The researchers contacted all the pharmaceutical companies in the Taiwanese pharmaceutical industry in the database to inform them about this research 
project and to confirm their current addresses. 
Of the 200 overall targeted respondents, a total of 61 non-probability anonymous selected respondents were collected from an online survey. The 
quantitative questionnaires were collected through an online questionnaire website. In the first part of the questionnaire, respondents specified the background 
information of their firm, including company history, company size, and the service each company provided. Of the 61 companies that responded, 14 (23%) 
had company turnovers below US$1.67 million, 15 (25%) had company turnovers over US$16.67 million, and 32 (52%) had company turnovers between 
US$1.67 million and US$1.67 million. In addition, all participating companies employeed fewer than 3,000 people. Therefore, 75% of the surveyed 
companies were categorized as small to medium-sized enterprises, which is the main characteristic of the Taiwanese business environment.  Number (66%) of 
the surveyed companies had fewer than 100 employees, 21 (34%) had more than 100 employeesand 7 (11%) had 300 employees.  
With regard to the companies’ age, there were three in the “less than 10 years” category, accounting for 4.92%, 36 in the “11–30 years”, accounting 
for 59.02%, 16 in the “31–50 years” category, accounting for 26.23%, five in the “51–80 years” category, accounting for 8.20%, and one in the “more than 81 
years” category, accounting for 1.64% (see Appendix A). 
 
Measures 
Constructs were derived from existing related concepts and scales publishedin various academic journals. In general, there are various developed 
measurement scales, all of which are a Likert type with management capabilities and operating performance. The researchers identified three domains for the 
construct of the uses of corporate reputation (value creation, strategic resources and corporate communication), and three domains for the construct of brand 
image strategy (brand segmentation, brand differentiation and brand positioning). The majority of measures focused on specific forms of support such as 
value creation (e.g. Devine and Halpern 2001; Eberl and Schwaiger 2005; Herbig et al. 1994), strategic resources (e.g. Roberts and Dowling 2002; Weigelt 
and Camerer 1988), and corporate communication (e.g. Gray and Balmer 1998). 
  
 
Data analysis and results 
Reliability and validity 
The validity and reliability of the questionnaire were tested through confirmatory factor analysis (CFA) and Cronbach’s coefficient as described below. In the 
measurement model, the results were as follows: “value creation scales” (Cronbach Alpha 0.938, Composite Reliability (CR) and the Average Variance 
Extracted (AVE) are 0.945 and 0.469 respectively); “value creation and resources scales” (Cronbach Alpha 0.955, CR and AVE 0.964 and 0.662 
respectively); “corporate communication scales” (Cronbach Alpha 0.840, CR and AVE are 0.892 and 0.547 respectively); “brand positioning scales” 
(Cronbach Alpha 0.851, CR and AVE are 0.902 and 0.650 respectively); “brand differentiation scales” (Cronbach Alpha 0.874, CR and AVE are 0.909 and 
0.590); and “brand segmentation scales” (Cronbach Alpha is 0.896, CR and AVE are 0.927 and 0.717). Allfactor loadings of the respective measurement 
indicators reached significance and all CRs and AVEs are both higher than 0.7 and 0.5. Therefore, the data analysis shows that the convergent validity of all 
the variables are within the acceptance range.  
 
Medicine price scales  
A new construct is suggested to act as a link between the relationship of the uses of corporate reputation and brand image strategy: namely, medicine price. In 
the measurement model of “medicine price scales,” the Cronbach Alpha is 0.906, and the factor loadings of the respective measurement indicators have 
reached significance; the Composite Reliability (CR) and Average Variance Extracted (AVE) are 0.924 and 0.577 respectively, indicating the CR and AVE 
are both higher than 0.7 and 0.5. Therefore, the data analysis shows that the convergent validity of “medicine price scales” is within the acceptance range.  
 
Discriminant validity analysis 
The study was conducted in line with the two criteria of discriminant validity proposed by Gaski and Nevin (1985):  the correlational coefficient between the 
two dimensions is less than 1; the correlational coefficients of the two dimensions are smaller than the individual Cronbach’s reliability coefficients, 
indicating the two dimensions possess discriminant validity. In addition, following Fornell and Larcker (1981), a third criterion for determining the 
discriminant validity was also tested: the correlational coefficients of the two dimensions are smaller than the square root of AVE, indicating that the two 
dimensions possess discriminant validity. In this study, SPSS 15.0 and PLS 1.04 were used to analyze the correlation coefficient matrixes of the measurement 
variables. The data analysis results as shown in Table 1 are consistent with the three discriminant validity criteria mentioned above, indicating good 
discriminant validity.  
< Insert Table 1 About Here > 
 
Hypothesis testing 
  
After testing the scale for reliably and validity, the hypothesized relationships were assessed. PLS (Partial Least Squares) was used at the expense of 
structural equation modeling (SEM), even though SEM is appropriate for simultaneously testing structural relationships among latent variables. With regard 
to the analysis procedures of PLS SEM, in this study the analysis proposed by Anderson and Gerbing (1988) was conducted. 
As the PLS gives emphasis to the capabilities of the formative indicators and reflective indicators, the explanatory power of the model is represented 
by R square, which indicates an ability of the cause indicators to explain the potential variables. The size of the load value determines the strength of the 
respective indicators in affecting the dimensions, and the path coefficients are standardized estimation values in which their significance can be determined by 
the p-value obtained from the Bootstrapping analysis. The structural modeling analysis results in this study are as follows: in the structural model, the forecast 
variables are “value creation”, “strategic resources” and “corporate communication”, which were used to predict the dependent variables including “brand 
segmentation”, “brand differentiation” and “brand positioning”. In terms of the regression model, with “brand segmentation” as a dependent variable, the 
standardized value for “value creation” is 0.232 (t-value=1.537), the standardized value of “strategic resources” is 0.164 (t-value=1.521), the standardized 
value of “corporate communication” is 0.517 (t-value=3.679) and the model’s explanatory power R is 0.723. In terms of the regression model, with “brand 
differentiation” as a dependent variable, the standardized value of “value creation” is 0.334 (t-value=2.459), the standardized value of “strategic resources” is 
0.143 (t-value=1.256), the standardized value of “corporate communication” is 0.477 (t-value=3.878) and the model’s explanatory power R is 0.783. In terms 
of the regression model, with “brand positioning” as a dependent variable, the standardized value of “value creation” is 0.327 (t-value=2.595), the 
standardized value of “strategic resources” is 0.363 (t-value=1.996), the standardized value of “corporate communication” is 0.278 (t-value=2.643) and the 
model’s explanatory power R is 0.808. A model with path values and t-values is shown in Figure 2. 
< Insert Figure 2 About Here > 
In this study, with “medicine price” as the regulatory variable, the effect of the uses of corporate reputation on brand image strategy was explored. 
The analysis results showed that the standardized estimate value of the uses of corporate reputation is 0.736 (t-value=11.444), the standardized estimate value 
of medicine price is 0.211 (t-value=3.223), the standardized estimate value of the regulatory effect variables between the uses of corporate reputation and 
brand image strategy is -0.177 (t-value=-3.068), while the explanatory power R of the model is 0.845. The findings show that medicine price has a negative 
moderating effect on the uses of corporate reputation in “brand image strategy”. In other words, the more recognized medicine price is, the less helpful its role 
will be in having an effect on the uses of corporate reputation in brand image strategy. The negative effect of medicine price on brand image strategy will 
interfere with the positive effect of the uses of corporate reputation in brand image strategy. A model of the moderating effect between the relationship of the 
uses of corporate reputation and brand image strategy is shown in Figure 3. 
< Insert Figure 3 About Here > 
In the second round analysis, based on Henseler et al. (2009), some items with a factor loading (absolute standardized outer loading) below 0.7 
( ) were deleted. Chin (1998) describes R square values of 0.67, 0.33, and 0.19 in PLS path models as substantial, moderate and weak, respectively. 
Therefore, in this second round of analysis, it is shown that the R square values of BD, BP and BS are 0.6536, 0.7508 and 0.6633, respectively. The average 
value of R square is 0.689233, which, according to Chin’s (1998) description, is “substantial”. 
 
Moderating effects 
  
The second model analysis tested the moderating role on each hypothesis. In Table 2 (path coefficient of moderating effects), the moderating effects of 
medicine price (PP) for each construct of the uses of corporate reputation (VC, SR and CC) on each construct of brand image strategy (BP, BD and BS) are 
shown, and none of the moderating effects are supported. However, the medicine price is supported as a predictor of BS, which shared 26% of variance (beta 
value or standard estimation) and its t-value was 2.7803. 
< Insert Table 2 About Here > 
In the third round analysis, several items from the first- and second-round analyses were deleted to refine the model by reducing cross-loadings, 
which consequently increased the discriminant validity of the model (Fornell and Larcker 1981; Henseler et al. 2009). For example, BD2 (loading=0.77) was 
deleted because of its cross-loading with BS and CC (0.63 and 0.61, respectively); BD5 was deleted because of its cross-loading with BP, BS and SR; SR5 
was deleted because of its cross-loading with BD, BP and CC; SR11 was deleted because of its cross-loading with BP; and VC16 was deleted because of its 
cross-loading with BS. 
Finally, in the fourth round analysis, according to Barclay et al. (1995), a rule of thumb for robust PLS path modeling estimations, the sample size in 
the inner path model should be larger than “ten times the largest number of structural paths directed at a particular construct” (Henseler et al. 2009). 
Therefore, because of the small number of respondents, based on the previous model of analysis, we simplified the model by separating one model into three 
simpler models for the fourth round of analysis. Table 3 shows the results of the hypotheses testing. 
< Insert Table 3 About Here > 
 
Discussion 
Theoretical contributions 
This research contributes to existing literature on reputation and other fields in several ways. First, most studies in corporate reputation literature have 
concentrated on the general concept of corporate reputation theoretically rather than relating it to actual practice. This study contributes to existing knowledge 
by linking the theoretical corporate reputation theory with a firm’s strategic usage of it in practice. There is a lack of literature investigating the relationship 
between corporate reputation and branding issues (Worcester 2009). Although a few studies addressing the uses of corporate reputation have already been 
conducted (e.g., Davies and Chun 2002), they have been done without empirical evidence explicating the relationships between these constructs. 
Second, this research advances current understanding about a generative process by which brand image strategy is formed and applied, with statistical 
evidence followed by the theory building. The current literature (e.g., Michell et al. 2001) has only conceptualized the direct impacts for each construct of the 
uses of corporate reputation on each brand image strategy, but none has empirically examined these relationships.  
Third, no previous study has empirically examined the moderating effects involved in creating brand image strategy in the pharmaceutical practice. 
This study finds that medicine price negatively moderates the impact of the overall uses of corporate reputation on overall brand image strategy.  
Fourth, the study provides partial evidence to a long-standing debate about how to construct the uses of corporate reputation. Some past studies 
suggest the link of corporate communication as one of several dimensions in the uses of corporate reputation. A firm’s corporate reputation can be used, as 
shown in the study, for corporate communication as it creates knowledge transfer, such as the communication of the sales staff to the customer, basic medical 
knowledge education, research outcomes updated, product information or effects revealed, and the newest research reported and delivered.  
  
In terms of methodology, the major contribution of this study is that the research is one of a few that tests reputation-and-branding-building models 
outside of the USA and Europe. Reputation researchers (e.g., Roberts and Dowling 2002) have highlighted a global trend in reputation management and 
raised their concerns about the necessity for cross-cultural research. Other researchers in general have also been aware of the applicability of their theories 
across nations and have encouraged new studies to establish their external validity (e.g., Boyacigiller and Adler 1991; Peng and Shyi 1991). The research to 
some extent responds to those calls for global investigations by testing a reputation-building model in Taiwan, a country in Southeast Asia. Examining the 
model in this setting could render additional insights into the extant literature, because Taiwanese customers and their cultural backgrounds are substantially 
different from those of western countries. 
 
Managerial implications 
The study indicates that corporate reputation is devised to protect firms from excessive interpretation by stakeholders. A company’s corporate reputation 
builds a relationship between the firms and its customers and firms can employ their corporate reputation to enhance the development of a sound relationship 
with their customers (see Shrum and Wuthnow 1988). This is based on the fact that corporate reputation is frequently used as a signal that contributes towards 
a thorough understanding of not just customers but, more importantly, of the key competitors of the firm (Milgrom and Roberts 1982). For this reason, 
corporate reputation is a device that can be devised to build a relationship between a company and all of its stakeholders. 
In summary, companies can apply seven activities: that is, they should (1) strive to enhance its value-chain activity to make it consistent with 
experiential value creation, (2) allocate resources to be more consistent with experiential value creation, (3) try to enhance the customers’ self-identity, (4) 
communicate more effectively with shareholders and other stakeholders to shape their perceptions about the firm, (5) build customer relationships, (6) 
negotiate with competitors to take advantage of joint resources and to ensure their product suits the market better, and (7) negotiate with the government to 
affect policy, all to improve their brand differentiation strategy and build best practice.  
 
Limitations and future research 
The study was not without limitations. First, this study is cross-sectional representing static relationships between variables in the researched framework. 
Second, the study was conducted in a single setting, which provided the researcher with a better control over market and environmental anomalies and 
industry effects, but this does limit the generalizability of findings. Third, this study used small-number sample size analysis because the entire number of 
targeted respondents is around 200 organizations.  
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Table 1 Discriminant validity analysis and correlational coefficients of variables 
Dimension  
Value 
creation 
Strategic 
resources 
Corporate 
communication  
Brand 
segmentation 
Brand 
differentiation 
Brand 
positioning 
Medicine 
price 
CR AVE 
Composite 
Reliability 
(CR) 
Average 
Variance 
Extracted 
(AVE) 
Value creation .777       0.945 0.469 
Strategic 
resources 
.829 .871      
0.964 0.662 
Corporate 
communication 
.751 .745 .818     
0.892 0.547 
Brand 
segmentation 
.730 .755 .805 .895    
0.927 0.717 
Brand 
differentiation 
.796 .790 .825 .947 .839   
0.909 0.590 
Brand 
positioning 
.826 .847 .762 .830 .867 .866  
0.902 0.650 
Product price .546 .586 .484 .636 .579 .527 .836 0.924 0.577 
Mean          
Variance          
Cronbach’s α 0.938 0.955 0.840 0.896 0.874 0.851 0.906   
        The diagonal value is the square root of AVE; CR represents Composite Reliability; AVE represents Average Variance Extracted; the 
lower triangle is   
        Pearson correlation. 
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Table 2 Path coefficient value of moderating effects (Please show only 
two digits after the decimal point) 
 
 
 
              Original 
Sample 
(O) 
Sample 
Mean 
(M) 
Standard 
Deviation 
(STDEV) 
Standard 
Error 
(STERR) 
T Statistics 
(|O/STERR|) 
Test 
results 
CC * PP -> 
BP 
-0.216 -0.099 0.1554 0.1554 1.3903 Rejected 
CC * PP -> 
BD 
0.1658 -0.0225 0.1876 0.1876 0.8838 Rejected 
CC * PP -> 
BS 
0.1817 0.1042 0.1677 0.1677 1.0835 Rejected 
SR * PP -> 
BP 
-0.0692 -0.1219 0.1473 0.1473 0.4699 Rejected 
SR * PP -> 
BD 
0.0787 0.199 0.2213 0.2213 0.3556 Rejected 
SR * PP -> 
BS 
-0.1506 -0.0874 0.1804 0.1804 0.835 Rejected 
VC * PP -> 
BP 
-0.051 -0.0369 0.1416 0.1416 0.3603 Rejected 
VC * PP -> 
BD 
-0.3136 -0.0767 0.2066 0.2066 1.5176 Rejected 
VC * PP -> 
BS 
-0.2312 -0.1696 0.1937 0.1937 1.1933 Rejected 
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Table 3 Standardized path coefficients and hypothesis validation of the research 
model (numbers based on fourth round analysis) 
 
Hypot
hesis 
Path Correlation between dimensions Path 
coefficie
nt 
t-
value 
Test 
results 
H1 β1 Value creation → Brand 
segmentation (VC→BS) 
0.39 2.71 Accepted 
H2 β4 Value creation → Brand 
differentiation (VC→BD) 
0.25 2.38 Accepted 
H3 β7 Value creation → Brand positioning 
(VC→BP) 
0.43 4.46 Accepted 
H4 β2 Strategic resources → Brand 
segmentation (SR→BS) 
- - Rejected 
H5 β5 Strategic resources → Brand 
differentiation (SR→BD) 
- - Rejected 
H6 β8 Strategic resources → Brand 
positioning (SR→BP) 
0.50 5.41 Accepted 
H7 β3 Corporate communication → Brand 
segmentation (CC→BS) 
0.40 2.76 Accepted 
H8 β6 Corporate communication → Brand 
differentiation (CC→BD) 
0.64 7.19 Accepted 
H9 β9 Corporate communication → Brand 
positioning (CC→BP) 
- - Partially 
supported 
H10 β10 Moderating effects of medicine 
price→Brand image  
- - Partially 
supported 
 
 
Figure 1 Research conceptual framework (Please change fonts in Figure 1 to Ariel and 
provide Figure in a raw format). 
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Figure 2 Path values (structural path relationships) and t-value (significance of structural 
path based on t-value) in brackets. 
 
 
 
  18 
 
Figure 3 Moderating effect between the relationship of the uses of corporate reputation and 
brand image strategy (Please change fonts in Figure 3 to Ariel and provide Figure in a raw 
format). 
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Appendix A Descriptive analysis table of company statistics 
 
Variable Category of information  
No. of 
sampl
es 
Percentag
e (%) 
Cumulative 
percentage (%) 
Firm history 
(1) less than 10 years 3 4.92 4.92 
(2) 10–30 years 36 59.02 63.93 
(3) 30–50 years 16 26.23 90.16 
(4) 50–80 years 5 8.20 98.36 
(5) Over 80 years 1 1.64 100.00 
Sales turnover 
(1) < 1 million pounds 14 22.95 22.95 
(2) 1 million to 2.99 million 
sterling pounds (£) 
17 27.87 50.82 
(3) 3 million to 9.99 million 
sterling pounds (£) 
15 24.59 75.41 
(4) Over 10 million sterling 
pounds (£) 
15 24.59 100.00 
How many 
people work 
for your 
company? 
(1) Fewer than 50 people 25 40.98 40.98 
(2) 51–100 people 15 24.59 65.57 
(3) 101300 people 14 22.95 88.52 
(4) More than 300 people 7 11.48 100.00 
Which 
department do 
you belong to? 
(1) Sales department 20 32.79 32.79 
(2) Marketing department 15 24.59 57.38 
(3) Management department 26 42.62 100.00 
Which 
position do 
you hold in 
your 
company? 
(1) Board chairman 3 4.92 4.92 
(2) General manager 10 16.39 21.31 
(3) Department manager 
48 78.69 100.00 
How many 
years have 
you worked in 
this 
company?  
(1) Less than 1 year 4 6.56 6.56 
(2) 2–3 years 8 13.11 19.67 
(3) 4–10 years 21 34.43 54.10 
(4) 11–20 years 15 24.59 78.69 
(5) More than 20 years 13 21.31 100.00 
Firm character 
(multiple 
choice) 
(1) A foreign-owned company 
(American company) 
1   
(2) A foreign–owned company 
(European company) 
0   
(3) A foreign–owned company 
(Asian company) 
2   
(4) A trader company 
(American company) 
7   
(5) A trader company 
(European company) 
9   
(6) A trader company (Asian 
company) 
22   
(7) Local company 38   
 
